Disease associated with equine coronavirus infection and high case fatality rate. by Fielding, CL et al.
UC Davis
UC Davis Previously Published Works
Title


















eScholarship.org Powered by the California Digital Library
University of California
Disease Associated with Equine Coronavirus Infection and High
Case Fatality Rate
C.L. Fielding, J.K. Higgins, J.C. Higgins, S. McIntosh, E. Scott, F. Giannitti, A. Mete, and N. Pusterla
Background: Equine coronavirus (ECoV) is associated with clinical disease in adult horses. Outbreaks are associated
with a low case fatality rate and a small number of animals with signs of encephalopathic disease are described.
Objectives: The aim of this study is to describe the epidemiological and clinical features of two outbreaks of ECoV
infection that were associated with an high case fatality rate.
Animals: 14 miniature horses and 1 miniature donkey testing fecal positive for ECoV from two related disease out-
breaks.
Methods: Retrospective study describing the epidemiological findings, clinicopathological findings, and fecal viral load
from affected horses.
Results: In EcoV positive horses, 27% (4/15) of the animals died or were euthanized. Severe hyperammonemia
(677 lmol/L, reference range ≤60 lmol/L) was identified in one animal with signs of encephalopathic disease that subse-
quently died. Fecal viral load (ECoV genome equivalents per gram of feces) was significantly higher in the nonsurvivors
compared to animals that survived (P = .02).
Conclusions and Clinical Importance: Equine coronavirus had a higher case fatality rate in this group of miniature
horses than previously reported in other outbreaks of varying breeds. Hyperammonemia could contribute to signs of
encephalopathic disease, and the fecal viral load might be of prognostic value in affected horses.
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Equine coronavirus (ECoV) infection was initiallyreported in neonatal foals (≤2 weeks of age) with
and without clinical signs suggestive of enteritis.1,2
Outbreaks of ECoV are described in adult horses at
racing facilities and boarding stables.3–5 Descriptions
of outbreaks of ECoV infection involving breeding
farms and young horses (<1 year of age) are not
reported.
Case fatality rates in the outbreaks have ranged
between 0 and 7%.3–5 In a case series of four boarding
stables, two of the horses that died had acute onset of
neurologic disease. A definitive cause for the neuro-
logic signs is not determined, but authors speculated
that hyperammonemia had contributed to the death of
these horses.3
Fecal shedding of ECoV after infection occurs in a
median of 4 days (range of 3–9 days).3 However, more
information is needed to confirm this finding as longer
periods of shedding could lead to unanticipated disease
transmission if quarantine periods are ended prema-
turely. In addition, a high viral load has been associ-
ated with adverse outcome in people with respiratory
coronavirus infection,6 but this has not been demon-
strated in horses.
The purpose of this study was to describe the
epidemiological and clinicopathological features of
two outbreaks of ECoV infection that likely origi-
nated at a large equine competition and subsequently
spread to two separate locations in Idaho and Cali-
fornia. The high case fatality rate, documentation of
hyperammonemic encephalopathy, and association
between viral load and death has not been previously
reported.
Materials and Methods
Case Histories and Clinical Examination
Both reported outbreaks from California (CA) and Idaho (ID)
initially involved horses that had recently returned from the
American Miniature Horse Association World Show in Texas in
October, 2013. Clinical examination findings were recorded at
presentation for veterinary care.
Virology and Bacteriology Testing
In each outbreak, initial cases of ECoV infection were con-
firmed by real-time PCR on feces. The PCR assay was based on
the detection of a specific 142 base-pair product of the N gene of
ECoV.3 Viral load was reported as genome equivalents per gram
of feces. A plasmid was constructed with the 142 bp amplicon
and 10-fold dilutions were used to obtain the slope and y-inter-
cept for load calculations. The equation is the absolute value of
the CP-y intercept/slope. Furthermore, a real-time PCR assay
targeting a universal sequence of the bacterial 16s rRNA gene
was used as quality control (ie, efficiency of DNA purifications
and amplification) and as an indicator of fecal inhibition.7 After
identification of ECoV in affected horses, subsequent screening of
the remaining horses in the herd was completed. Repeated testing
was performed daily on six horses from the CA outbreak until at
least three consecutive negative samples were obtained. Other
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common enteric pathogens of horses, including Salmonella enteri-
ca, Clostridium difficile, Clostridium perfringens, Lawsonia intra-
cellularis, and Neorickettsia risticii were also investigated in feces
of four of the sick horses by specific PCR.3
Clinical Pathology
Complete blood cell count and biochemical panels were
performed on 8 horses. Blood ammonium concentration was
measured in 6 ECoV-infected horses with clinical signs. For a
complete list of variables that were evaluated refer to Table 1.
Statistical Analysis
Data are reported as median (range). A Mann–Whitney test
was used to compare viral load between horses testing positive
for ECoV that died versus those horses that survived. Signifi-
cance level was set at P < .05.
Results
Epidemiological and Clinicopathological Features,
and Virology Testing
Available clinical examination and clinicopathologi-
cal data for animals from both outbreaks (CA and ID)
are combined in Table 1. The total number of horses
in each farm was 19 (CA) and 8 (ID). ECoV testing
was performed with all horses for a total of 27 animals
from both farms combined (19 from CA and 8 from
ID). Fifteen of the animals (56%) tested positive. 10 of
the 15 animals (67%) testing positive (6 from CA and
4 from ID) manifested clinical disease including but
not limited to colic, fevers, lethargy, and inappetance,
while 5 (33%) of 15 positive animals remained asymp-
tomatic. Four of the horses positive for ECoV (27%)
tested negative for S. enterica, C. difficile, C. perfrin-
gens, L. intracellularis, and N. risticii.
In the CA outbreak, the first horse displayed clinical
signs including fevers (39.2°C), lethargy, and inappe-
tance approximately 9 days after leaving the competi-
tion. Over a 5-day period, 2 additional horses that had
not attended the show displayed similar clinical signs
(fevers up to 39.2°C) and were quarantined as a group
for approximately 14 days. At the end of the quaran-
tine period, the horses were returned to the herd and
approximately 3 days later, another individual with
severe clinical signs died. Despite isolation and
enhanced biosecurity protocols at the farm, 7 other
animals tested positive for ECoV over the next
12 days. These animals showed a range of clinical
signs from no significant changes to fevers, lethargy,
and mild colic.
In addition to the initial animal that died in trans-
port to the hospital, an 11-year-old miniature horse
mare died during hospitalization. She initially was pre-
sented for veterinary care with mild signs of colic, but
had a normal rectal temperature (37.6°C), increased
heart rate (60 bpm), and increased respiratory rate
(30 bpm). Initial blood work showed leukopenia
(990 cells/lL) because of lymphopenia (640 cells/lL)
and neutropenia (340 cells/lL), and hyperlactatemia
(3.3 mmol/L).
Table 1. Age, clinical, and clinicopathological findings in ECoV-positive horses.
Variable (Units) Reference Range Median (range)
Number of Animals with Abnormal
Results/Number of Animals Tested
Age (years) N/A 6 (0.5–19) 15
Temperature (°C) 37.2–38.311 37.9 (34.7–40.0) 5/11
Heart rate (bpm) 28–4411 46 (40–72) 5/10
Respiration (bpm) 8–1511 16 (10–32) 6/10
Albumin (g/dL) 2.6–3.712 3.2 (2.0–3.6) 2/8
AST (U/L) 140–30613 331 (300–549) 2/7
BUN (mg/dL) 15.2–32.513 18 (14–37) 1/8
Ca (mg/dL) 10.1–12.613 12.0 (5.1–13.4) 5/8
Creatinine (mg/dL) 0.7–1.413 1.0 (0.7–1.2) 0/7
GGT (U/L) 6–2913 23.5 (10–169) 2/8
Glucose (mg/dL) 68–12613 122.5 (75–234) 2/8
K (mmol/L) 3.7–5.313 2.9 (2.5–4.4) 6/8
Total Bilirubin (mg/dL) 1.0–2.012 1.2 (0.4–2.3) 3/8
TP (mg/dL) 5.2–7.913 6.75 (5.5–7.5) 0/8
Na (mmol/L) 132–14013 135.5 (129–139) 2/8
Globulin (g/dL) 2.6–4.012 3.75 (2.7–4.2) 2/8
CK (U/L) 111–94113 322 (192–454) 0/8
TCO2 (mmol/L) 24–32
13 29 (27–32) 0/6
Ammonia (lmol/L) 8–6312 22 (12–677) 1/6
Lymphocytes (cells/lL) 3,149–12,55813 1,490 (330–2,840) 8/8
WBC (cells/lL) 6,100–18,20013 3,675 (960–7,240) 5/8
Neutrophils (cells/lL) 1,638–7,23813 1,775 (30–5,180) 4/8
Platelets (cells/lL) 100,000–270,00014 120,500 (91,000–157,000) 2/8
PCV (%) 23.7–42.713 33 (22–57) 3/8
Lactate (mmol/L) 1.1–1.812 1.2 (0.9–3.3) 1/4
Fibrinogen (mg/dL) 100–40012 463 (200–609) 1/4
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Eight hours after examination, the mare exhibited cir-
cling, head pressing, nystagmus and decreased pupillary
light reflex. There was hyperlactatemia (12.7 mmol/L)
and severe hyperammonemia (677 lmol/L, reference
range ≤63 lmol/L). Over a 2-hour period, clinical signs
progressed and the mare became recumbent, developed
respiratory and cardiovascular arrest, and died.
Both horses that died in the CA outbreak were sub-
mitted to the California Animal Health and Food
Safety Laboratory in Davis, CA for complete post-
mortem examination (data not shown). In both ani-
mals, small intestinal content tested positive for ECoV
by PCR. In the first animal that died, there was severe,
diffuse necrotizing enteritis. In the second animal with
hyperammonemia, there was Alzheimer Type II astro-
cytosis in the cerebral cortex.
Serial testing for ECoV was completed for 6 horses
that tested positive in the CA outbreak. The mean
shedding time was 3.5 days, however one horse contin-
ued shedding for a total of 11 days (range 2–11 days).
The daily fecal sample collection began on the first
sick day (first day that clinical signs were observed),
but healthy individuals were not repeatedly tested. In
the CA outbreak, 3 animals had clinical signs compati-
ble with ECoV infection approximately 2 weeks before
the remaining animals became symptomatic. PCR test-
ing was not performed at that time and these 3 horses
tested PCR negative for ECoV at the time the resident
horses developed disease.
In the ID outbreak, resident farm horses displayed
clinical signs of disease including decreased appetite,
lethargy, and fevers ≤38.9°C approximately 2–3 days
after show horses returned from competition (Ameri-
can Miniature Horse Association World Champion-
ship Show). The 4 horses that returned from the show
did not exhibit clinical abnormalities. A total of 7
horses tested fecal positive for ECoV on real-time
PCR. Of these 7 horses, 4 (57%) had clinical signs of
disease whereas 3 (43%) animals did not have clinical
abnormalities. The first horse had signs of lethargy
and anorexia 48 hours after exposure to the show
horses. This horse was severely ill by 60 hours post
exposure. Clinical signs in affected horses included
fevers up to 38.9°C (three horses), tachycardia (one
horse), encephalopathic signs (circling, head-pressing,
and/or nystagmus in two animals), and lethargy (all
horses). Of the 4 horses with abnormal clinical signs, 2
(50%) died during the course of disease. A miniature
donkey (one of the animals that died) displayed signs
of rapidly progressive nystagmus, decreased mentation,
and recumbency. The donkey presented for veterinary
care 36 hours after the onset of clinical signs, but
because of rapid progression over the next 12 hours,
the donkey was euthanized. The other animal that
died, a miniature horse, developed an acute decrease in
packed cell volume from 33% to 16% with ulcerations
of the oral mucosa and tongue.
Maximum viral loads measured in the feces for each
horse (n = 15) had a median of 9.7 9 106 (1.2 9 104
to 2.4 9 109) ECoV genome equivalents per gram of
feces with a corresponding Cp value of 27.10. Horses
with ECoV that died had a significantly higher viral
load as compared to horses that survived (P = .02).
The median viral load was 9.5 9 104 (1.1 9 104 to
1.4 9 107) ECoV genome equivalents per gram of
feces in survivors with a corresponding Cp value of
33.93. This compared to horses that died 2.9 9 107
(1.4 9 107 to 2.4 9 109) with a corresponding Cp
value of 25.01. The specific mortality rate for the 2
outbreaks combined was 15% (4/27). This was calcu-
lated as the number of animals that died divided by
the number of all animals. The number of animals
testing positive for EcoV that died was 27% (4/15).
In addition to the severe hyperammonemia docu-
mented in the animal that died, blood ammonium was
measured in 5 other animals that tested positive for
EcoV and no other animals had values outside of the
reported reference range (Table 1) and none of the
other tested animals displayed any neurologic abnor-
malities.
Discussion
The proportion of positive animals that died (27%)
in this report is higher than the case fatality rate
reported in previous outbreaks (7%).3 The deaths did
not occur in stressed show horses, but in resident
horses. The increased rate could reflect the virulence of
the ECoV strain, host or environmental factors.
Amount of viral particles being shed in manure was
evaluated in horses. While the 4 animals that died had
variable viral loads, as a group they were statistically
significantly higher than surviving animals. The minia-
ture horse that died in the ID outbreak initially had a
low viral load despite significant clinical disease, but
had a much higher viral load on the second fecal
sample submitted. In human coronavirus infections,
clinical outcome and death are highly correlated with
viral load.8 Results in this group of horses suggest that
viral load in ECoV infection is related to case fatality
as well.
Two of the 4 deaths described in a previous out-
break were associated with the onset of signs of
encephalopathic disease.3 Hyperammonemia may have
been responsible for the neurological signs and con-
tributed to the death of the horses.3 The current study
documents a fatal case of hyperammonemia associated
with ECoV infection. It is possible that hyperammone-
mia could be common when encephalopathic signs are
present in horses with ECoV and that severe cases are
associated with an increased risk of death.
Severe hyperammonemia is likely because of
increased ammonia production within or absorption
from the gastrointestinal tract. Reports of equine
hyperammonemia have speculated that overgrowth of
urease producing bacteria and increased absorption
might contribute to the increased levels of ammo-
nia.9,10 Early treatment for presumptive hyperammone-
mia might be prudent, if there is a high suspicion for
an ECoV outbreak with associated encephalopathic
signs in cases where testing of ammonium levels is not
readily available.
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Idiopathic equine hyperammonemia has been
reported in case reports and retrospective case series.9,10
The majority of these reported cases had clinical signs
consistent with ECoV infection (inappetance, depres-
sion, fever, colic, and diarrhea). Some of these cases
have occurred as outbreak situations. Some of these
cases of previously reported idiopathic hyperammone-
mia could have been associated with ECoV infection.
Further study would be needed to determine if
younger animals or certain breeds are more severely
affected. The recent studies have described outbreaks
in larger boarding stables or competition barns in full
sized horses.3–5
Four of the horses in the present study were tested
for other common enteric pathogens and were negative,
but the findings of the paper would have been stronger
if all other horses had been tested for other pathogens.
EcoV was commonly identified as a coinfection with
other pathogens in foals with diarrhea.1 To the authors’
knowledge, this has not been described in adult horses.
Fecal shedding in this study was as long as 11 days
in one animal, compared to 9 days in a previous
study.3 The presumed initially infected animals were
quarantined for 14 days after the cessation of clinical
signs in CA. After return to the herd, other animals
became sick within a few days. This suggests that fecal
shedding could have occurred for longer than 14 days.
If confirmed, this would indicate that longer quaran-
tine periods might be needed for animals returning
from competition or being newly introduced into the
herd. One horse in the ID outbreak that was initially
negative on PCR for ECoV despite showing clinical
signs. This could have been because of the ileus and
delayed passage of manure exhibited by this horse.
That the horse was positive on retesting shows the
importance of repeat testing in horses that are negative
initially, particularly if they are not passing normal
amounts of feces.
In conclusion, these outbreaks of ECoV were associ-
ated with younger animals, a higher case fatality rate,
and a longer fecal shedding period. Severe hyperam-
monemia was recognized in one animal with acute
encephalopathic signs and death. If acute neurologic
signs develop, hyperammonemia should be suspected
and treated aggressively. In addition, viral load might
be a factor to consider when determining prognosis.
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